Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walid Ayoub

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Cancer Causes & Control : CCC|January 20, 2012
Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case-control studyNghi B Ha, Nghiem B Ha, Aijaz Ahmed, et al.
Alimentary Pharmacology & Therapeutics|March 17, 2026
Assessing Major Adverse Liver Outcomes With Baclofen Compared to Acamprosate in Compensated Alcohol-Associated CirrhosisYee Hui Yeo, Sepideh Mehravar, Ellen Choi, et al.
Hepatology (Baltimore, Md.)|July 9, 2022
Machine learning models are superior to noninvasive tests in identifying clinically significant stages of NAFLD and NAFLD-related cirrhosisDevon Chang, Emily Truong, Edward A Mena, et al.
Gastro Hep Advances|August 12, 2024
COVID-19 Pandemic Impact on Diagnosis, Stage, and Treatment of Hepatocellular Carcinoma in the United StatesBhupinder Kaur, Yee Hui Yeo, Jeff Liang, et al.
Hepatology (Baltimore, Md.)|April 16, 2022
Racial and ethnic disparities in early treatment with immunotherapy for advanced HCC in the United StatesJoseph C Ahn, Marie Lauzon, Michael Luu, et al.
Clinical and Translational Gastroenterology|June 3, 2024
Impact of the Early COVID-19 Pandemic on Incidence and Outcomes of Hepatocellular Carcinoma in the United StatesJeff Liang, Yi-Te Lee, Yee Hui Yeo, et al.
Digestive Diseases and Sciences|November 20, 2021
Duodenal Microbiome and Serum Metabolites Predict Hepatocellular Carcinoma in a Multicenter Cohort of Patients with CirrhosisTien S Dong, Jonathan P Jacobs, Vatche Agopian, et al.
The American Journal of Gastroenterology|August 10, 2023
Immunotherapy and Transarterial Radioembolization Combination Treatment for Advanced Hepatocellular CarcinomaYee Hui Yeo, Jeff Liang, Marie Lauzon, et al.
Hepatology Communications|April 27, 2026
Liver transplantation is the major determinant of ≥10-year survival in patients with hepatocellular carcinomaMohammad Saeid Rezaee-Zavareh, Joseph C Ahn, Hyunseok Kim, et al.
Transplantation Direct|November 2, 2020
Increase in Alcoholic Hepatitis as an Etiology for Liver Transplantation in the United States: A 2004-2018 AnalysisNabil Noureddin, Ju Dong Yang, Naim Alkhouri, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Cancer Causes & Control : CCC|January 20, 2012
Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case-control studyNghi B Ha, Nghiem B Ha, Aijaz Ahmed, et al.
Alimentary Pharmacology & Therapeutics|March 17, 2026
Assessing Major Adverse Liver Outcomes With Baclofen Compared to Acamprosate in Compensated Alcohol-Associated CirrhosisYee Hui Yeo, Sepideh Mehravar, Ellen Choi, et al.
Hepatology (Baltimore, Md.)|July 9, 2022
Machine learning models are superior to noninvasive tests in identifying clinically significant stages of NAFLD and NAFLD-related cirrhosisDevon Chang, Emily Truong, Edward A Mena, et al.
Gastro Hep Advances|August 12, 2024
COVID-19 Pandemic Impact on Diagnosis, Stage, and Treatment of Hepatocellular Carcinoma in the United StatesBhupinder Kaur, Yee Hui Yeo, Jeff Liang, et al.
Hepatology (Baltimore, Md.)|April 16, 2022
Racial and ethnic disparities in early treatment with immunotherapy for advanced HCC in the United StatesJoseph C Ahn, Marie Lauzon, Michael Luu, et al.
Clinical and Translational Gastroenterology|June 3, 2024
Impact of the Early COVID-19 Pandemic on Incidence and Outcomes of Hepatocellular Carcinoma in the United StatesJeff Liang, Yi-Te Lee, Yee Hui Yeo, et al.
Digestive Diseases and Sciences|November 20, 2021
Duodenal Microbiome and Serum Metabolites Predict Hepatocellular Carcinoma in a Multicenter Cohort of Patients with CirrhosisTien S Dong, Jonathan P Jacobs, Vatche Agopian, et al.
The American Journal of Gastroenterology|August 10, 2023
Immunotherapy and Transarterial Radioembolization Combination Treatment for Advanced Hepatocellular CarcinomaYee Hui Yeo, Jeff Liang, Marie Lauzon, et al.
Hepatology Communications|April 27, 2026
Liver transplantation is the major determinant of ≥10-year survival in patients with hepatocellular carcinomaMohammad Saeid Rezaee-Zavareh, Joseph C Ahn, Hyunseok Kim, et al.
Transplantation Direct|November 2, 2020
Increase in Alcoholic Hepatitis as an Etiology for Liver Transplantation in the United States: A 2004-2018 AnalysisNabil Noureddin, Ju Dong Yang, Naim Alkhouri, et al.
Pageof 3